Ligand Pharmaceuticals
LGND
#4111
Rank
โ‚น194.57 B
Marketcap
โ‚น10,297
Share price
0.69%
Change (1 day)
64.98%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): โ‚น128.21

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น135.95. In 2022 the company made an earnings per share (EPS) of -โ‚น171.45 a decrease over its 2021 EPS that were of โ‚น299.60.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น128.21-174.78%
2022-โ‚น171.45-157.23%
2021โ‚น299.60-2571.43%
2020-โ‚น12.12-100.46%
2019โ‚น2,651353.48%
2018โ‚น584.491025%
2017โ‚น51.95-700%
2016-โ‚น8.66-100.87%
2015โ‚น1,0011859.32%
2014โ‚น51.095.36%
2013โ‚น48.498.0704505322479E+18%
2012โ‚น0.0000000000-100%
2011โ‚น42.43-194.23%
2010-โ‚น45.03548.38%
2009-โ‚น6.94-98.7%
2008-โ‚น535.13-136.52%
2007โ‚น1,465-787.8%
2006-โ‚น213.01-14.58%
2005-โ‚น249.38-21.31%
2004-โ‚น316.92-55.15%
2003-โ‚น706.5881.33%
2002-โ‚น389.662.74%
2001-โ‚น379.27-45.93%
2000-โ‚น701.39-14.56%
1999-โ‚น820.88-45.52%
1998-โ‚น1,507-3.97%
1997-โ‚น1,569132.31%
1996-โ‚น675.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น1,225 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น31.17-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น303.13 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น157.74 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น161.06 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น470.13 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น343.77 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น443.35 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1,220 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA